Premium
Prognostic impact and therapeutic implications of sentinel lymph node micro‐metastases in early‐stage breast cancer patients
Author(s) -
Viehl Carsten T.,
Langer Igor,
Guller Ulrich,
ZanettiDällenbach Rosanna,
Moch Holger,
Wight Edward,
Oertli Daniel,
Zuber Markus
Publication year - 2011
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21693
Subject(s) - medicine , stage (stratigraphy) , breast cancer , sentinel lymph node , lymph node , adjuvant therapy , axillary lymph node dissection , dissection (medical) , cancer , axillary dissection , sentinel node , radiology , oncology , paleontology , biology
The prognostic value of sentinel lymph node (SLN) micro‐metastases and the question whether patients with SLN micro‐metastases should undergo axillary lymph node dissection remain a matter of great debate. Based on the current literature and on our own data, we provide suggestive evidence that SLN micro‐metastases in early stage breast cancer patients appear to have prognostic value and should impact the decision‐making regarding adjuvant therapy, however, do not necessarily require further surgical treatment. J. Surg. Oncol. 2011;103:531–533. © 2011 Wiley‐Liss, Inc.